Report Keyword:

China Massive Health Industry Report (2016-2021), Market Outlook and Investment Opportunity

China Massive Health Industry Report (2016-2021), Market Outlook and Investment Opportunity

Last Update:2016-09-19

Form of services:Book + (pdf or doc file) + CD

Send method:EMS 2-3 days for delivery

English Service:+86 0755 33220413

Chinese Service:+86 800-8306390 800-8306395

E-mail:service.en@qianzhan.com

Report price:$7900   Print: $7800   CD: $7800

Online Consultation
Special statement:
Recently we find there are some sites steal report contents from Qianzhan.com who put those contents on their sites for sale by making a little changes about the contents or remaining the same which deceives buyers(e.g. unable to get full or correct reports, or main body differs from contents that announced on sites).Therefore, we recommend paying a visit to Qianzhan personally or by your friends, and make payment after confirmation. Special statement: Qianzhan is the only and right holder of all the research reports, and has never used a third party to sell any reports, please be aware of the trademark " " when purchasing. Qianzhan is the largest and strongest consultancy, who owns the greatest number of researchers. Here followed "Nine standards of companies' identificatios"。

This table of content is original, without written permission of Qianzhan, any unit or individual shall not use, copy, or transfer the reports.

Preface

Table of Content

In recent years, China's research and development costs of drugs are increasing while the difficulty of drug development and market cycle are expanding. In the large environment of rapidly rising costs of raw materials especially traditional Chinese medicine, the pharmaceutical industry suffers from essential drug system, bidding and management of drug prices and other factors. Competition of prescription drugs is increasing. Pharmaceutical companies extend to "massive health" domain, develop new business and expand new markets, which becomes imminent of the transformation of economic development mode and to seek new growth points.

At the same time, for the pharmacy, the pure drug profits fell seriously. "Parity" gradually comes to an end. The terminal is in urgent need of innovative formats; while at the same time, consumers need a platform that can provide health services and health care; therefore, pharmacies' major health strategy emerges. Laying some of the high-margin product varieties in pharmacies is suitable for terminal appetite. Massive health strategy has market demands and the potential to be tapped. However, very few companies succeed in the current major health market.

This report analyzes massive health of the domestic pharmaceutical companies, pharmacies; investment potential of subdivided markets of massive health; combining a large number of domestic and foreign "massive health" cases, analyzes the reasons for their success or failure; summarizes a truly effective "massive health" road, to help enterprises avoid detours, wrong ways in the transformation and upgrading. It helps enterprises preparing to enter massive health achieve big successes and achieve a qualitative leap in the development of enterprises.

This report is based on professional tracking and research by Forward Intelligence on massive health industry. It uses scientific analysis models and analyses comprehensively and accurately the structure system from the overall height of the industry for you.

This report is based on various aspects of the macroeconomic environment of the industry like economy, policy, and society and does comprehensive and in-depth analysis of the current development status, typical cases and prospects of massive health strategy. It describes the development of massive health strategy in different pharmaceutical companies, pharmaceutical companies and enterprises of other natures. It also describes development experience of the leading international and domestic companies.

Meanwhile, based on first-hand market data of the whole industry in the past five years, it can allow you to fully and accurately understand main points and key points of implementation of massive health strategy in enterprises.

The greatest feature of this report is forward-looking, timeliness and practicality. This report is a rare quality for drug manufacturing enterprises, pharmacies and other medical institutions, medical / health institutions and investment companies to accurately understand the latest developments of the industry, grasp market opportunities, make the right business decisions and clear corporate directions. It is also the industry's first on comprehensive and systematic analysis of massive health strategy and typical cases.

This report will help drug manufacturing enterprises, pharmacies and other medical institutions, health care products manufacturers accurately understand the latest developments of the industry and early detect blank points of industry market, opportunities, growth and profitability points ...... it will help prospectively grasp unmet market needs and trends of the industry and become a good advantage for sustainable development, effectively avoid the investment risks from the industry, more efficiently consolidate or expand appropriate strategic target markets, and firmly grasp the initiative authority in market competition.


Massive Health" related reports »

Purchase Mode:

1. English Service:  +86 0755 33220413

2. Chinese Service:  +86 8008306390 8008306395

3. Mail Order:  service.en@qianzhan.com

4. Online Order:  Click "Order Now" button on this page

5. Purchase On-site:  19F Block A, First World Plaza, Hongli West Rd, Futian District, Shenzhen China

Warm tips:
  • 1. Please be aware of " Qianzhan " trademark, qianzhan has never used any third to sell reports, please make a phone call and purchase it directly.
  • 2. You are warmly welcome to visit Qianzhan, and close transaction after confirmation.
Industry Research
·Energy and Environment»
New Energy Natural Gas Energy Conservation Water Resources Coal Electricity Others
·Recreation and Sports»
Education Advertisement Film and Television Publication Packing and Printing Sports Resort Hotel Catering Internet Animation Others Media
·Financial Services»
Banking Insurance Securities Leasing Credit Others
·Transport Logistics and Supporting»
Water Transport Airport Road Transport Logistic Distribution Vehicle and Fittings Post-Market Others
·Medical and Health»
Medical Device Biomedicine Medical Institution Healthcare and Nursing Medicine and Pharmacy Others
·Retail or FMCG»
Retail Commercial Trade Food Beverage Dairy Product Seasoning Wine and Tobacco Cosmetics Cleaning Product Daily Necessities Others
·Real Estate and Construction»
Real Estate Real Estate Intermediary Public Safety Construction Engineering Survey and Design Building Materials Housing Accomodation Others
·Mechanical Manufacturing»
Precision Instrument Transport Instrument Electricity Supporting Equipment Special Equipment General Equipment Others
·New Chemical Material»
Ink and Pigment Coating Chemical Fibres Synthetic Fibres Chemicals Industrial Chemicals Rubber Plastics Basic Chemicals Others
·Light Textile and Clothing»
Luxury Jewelry Leather Raw Materials Shoes and Hats Clothing Textile Others
·Household Appliance and IT»
White Goods Optic Instrument Electrical Component Semiconductor Brown Goods Small Appliances Communication IT Consumer Electronics Others
·Minerals and Metallurgy»
Metal Product Metallurgy Non-Ferrous Metal Steel Mining Industry Others
Copyright Notice

1. The copyright of this report is reserved by Qianzhan Business Information Co., Ltd. (Industry Research Institute of Qianzhan), the shipment and post-sale service is handled by the issue department of Qianzhan Business Information Co., Ltd. (Industry Research Institute of Qianzhan). The only copyright of all research report products of our company is reserved; we did not authorize any third party sales agent, if you are to purchase our report, please contact our customer service directly.

2. A limited of customers are offered with our reports with compensation; those reports are only for internal usage and are only for researching and analyzing purposes. We will not be responsible for any misunderstanding or legal issues caused by external usage or references with the report.

More>>
Beginner's Guide
Order Reference
Delivery & Payment
Sale protection
Service Hotline
  • Order Hotline:+86 800-830-6390
  • Customer service:
    +86 800-830-6395
    +86 400-068-7188